PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 4.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $2,000 | -96.0% | 800 | -94.2% | 0.00% | – |
Q2 2014 | $50,000 | +61.3% | 13,700 | +97.9% | 0.00% | – |
Q1 2014 | $31,000 | -50.0% | 6,924 | -57.0% | 0.00% | – |
Q4 2013 | $62,000 | -97.7% | 16,113 | -97.3% | 0.00% | -100.0% |
Q3 2013 | $2,724,000 | -0.3% | 601,237 | +8.1% | 0.00% | 0.0% |
Q2 2013 | $2,731,000 | – | 556,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 13,275,000 | $13,541,000 | 0.88% |
Broadfin Capital, LLC | 3,338,570 | $3,405,000 | 0.21% |
Spark Investment Management LLC | 229,600 | $234,000 | 0.03% |
Baillie Gifford | 6,406,099 | $6,534,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 349,546 | $357,000 | 0.01% |
A.R.T. Advisors, LLC | 80,108 | $81,000 | 0.00% |
Psagot Value Holdings Ltd. | 101,876 | $103,000 | 0.00% |
WEDBUSH SECURITIES INC | 18,000 | $18,000 | 0.00% |
TFS CAPITAL LLC | 31,234 | $32,000 | 0.00% |
VAN ECK ASSOCIATES CORP | 106,208 | $108,000 | 0.00% |